Wed Aug 7, 2002
By LAURAN NEERGAARD, AP Medical Writer
WASHINGTON (AP) - The government is beginning a $30 million study to determine once and for all whether chelation therapy offers any benefit for sufferers of heart disease.
Chelation therapy is the main treatment for lead poisoning. A manmade amino acid called EDTA is seeped into patients' blood, through a vein, to sop up the toxic metal so it can be excreted in urine.